·
Cell and Molecular Biologist with a
robust background in translational
research, specializing in identifying
novel molecular biomarkers, drug
targets, and mechanism of action for
advancing early cancer diagnosis and
targeted cancer treatment.
·
Recognized for a proven track record
of scientific innovation, evidenced
by:
○
15+ scientific papers (6 as
first/co-first author) having direct
clinical development implications;
800+ citations.
○
20+ new collaborations; Presentations
of scientific data in 10+
national/international conferences.
○
$350,000 as personal grant award
acquisition from 10 foundations.
·
Exemplary collaborator and
communicator with deep expertise in
latest culture models, molecular
biology techniques, assay development
and Good Laboratory Practice (GLP).
Demonstrated ability to effectively
manage multiple projects, exhibiting
exceptional organizational skills and
keen attention to detail, leveraging
innovative thinking to drive research
forward.
·
Certified Medical Affairs Specialist
with an understanding of clinical
study and trials, contributing to
regulatory submissions and fostering
relationships with Key Opinion Leaders
(KOLs), Contract Research
Organizations (CROs), and other key
stakeholders.